US Patent Issued to NEWAMSTERDAM PHARMA on Sept. 15 for "Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases" (British, Japanese, Dutch Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,171, issued on Sept. 15, was assigned to NEWAMSTERDAM PHARMA B.V. (Naarden, Netherlands).

"Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases" was invented by John Ford (Cambridgeshire, Great Britain), Patrick Round (Suffolk, Great Britain), John Kastelein (Amsterdam), Atsuhiro Kawaguchi (Osaka, Japan), Koichi Tomiyasu (Osaka, Japan) and Kozo Oka (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a cholesteryl ester transfer protein (CETP) inhibitor:(Compound A) for use in the treatm...